Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Beurs gesloten - NYSE 22:00:00 30-07-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2,990 USD +4,18% Intraday-grafiek van Perspective Therapeutics, Inc. +1,36% +8,73%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+4,18%+1,36%-12,32%-23,33%+8,73%-22,94%-47,54%-56,43%-61,17% 327 mln.
-0,80%+6,30%+5,67%+20,30%+6,02%-1,72%+13,00%-17,67%+212,10% 48,95 mld.
-3,95%+14,70%+23,07%+50,15%+5,49%+24,15%+6,27%-4,00%+202,49% 40,75 mld.
+6,22%+1,81%+2,61%+33,34%+141,27%+419,17%+632,08%+570,98% - 38,46 mld.
-1,57%-1,44%+13,02%+9,08%+6,01%+7,38%+50,35%+1,73%+1.142,11% 36,38 mld.
+5,56%+11,70%+6,03%-2,21%+10,22%+11,64%+51,50%-11,63%+159,73% 28,45 mld.
-0,39%-0,63%-5,87%+9,46% - - - - - 16,62 mld.
-1,13%-4,54%+9,20%+38,13%+2,96%+32,10%+128,42%+228,69% - 16,33 mld.
-7,10%-2,81%-4,71%+39,89%-9,16%-8,80%-34,16%-31,96%+115,06% 13,65 mld.
-0,06%-2,81%+0,62%+19,22%+9,94%+3,16%+10,08%-30,88%+104,50% 13,56 mld.
-0,08%+2,32%+3,45%+40,52%+17,62%+33,16%+11,97%-42,34%+165,29% 11,31 mld.
0,00%+0,36%+1,95%+30,21%+22,48%+24,81%-13,63%-40,25%+153,23% 11,22 mld.
+0,09%-5,98%+30,25%+16,04%-9,88%+79,64%+517,88%+258,68%+2.514,46% 10,63 mld.
+0,07%+0,03%+1,18%+62,02%+77,93%+257,09%+527,57% - - 10,08 mld.
-3,25%-9,43%+25,03%+21,04%+26,66%+9,65%+37,29%-61,23% - 9,18 mld.
-1,41%-4,64%-32,80%-28,73%-32,65%+22,85%+28,60%+43,46%+40,17% 8,93 mld.
+4,24%+2,37%+13,10%+40,08%+58,74%+153,83%+614,64%+180,48% - 8,55 mld.
-0,86%0,00%+6,01%+19,87%-12,44%-22,13%-20,69%-29,65%+33,43% 8,65 mld.
+1,67%-3,05%-6,68%+32,00%+37,53%+142,82%+389,08%+77,82% - 8,66 mld.
+3,50%-5,55%-4,51%+48,41%+78,81%+79,13%+70,87%+93,39%+0,95% 8,11 mld.
Gemiddelde +0,29%+2,00%+3,72%+23,77%+23,49%+65,52%+156,50%+62,73%+367,87% 17,44 mld.
Gewogen gemiddelde per kap. +0,26%+4,98%+6,76%+25,45%+26,99%+76,61%+152,56%+86,59%+409,59%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.